[Treatment-associated neurological symptoms of cancer patients and their treatment].
Therapieassoziierte neurologische Symptome onkologischer Patienten und deren Behandlung.
Checkpoint inhibitors
Encephalopathy
Myopathy
Targeted therapies
Toxic neuropathy
Journal
Der Nervenarzt
ISSN: 1433-0407
Titre abrégé: Nervenarzt
Pays: Germany
ID NLM: 0400773
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
pubmed:
16
5
2019
medline:
3
9
2019
entrez:
16
5
2019
Statut:
ppublish
Résumé
With the increasing understanding of the specific molecular and cellular pathogenesis of cancer, systemic cancer treatment has become much more targeted and in part substantially more effective. The increased number of long-term survivors and the number of highly specific targeted therapies have resulted in a wide range of neurological complications. Neurologists are increasingly confronted with previously unknown neurological complications of cancer treatment. A profound understanding of the molecular and cellular mechanisms of action of anticancer drugs is the key for a prompt diagnosis and appropriate treatment of these treatment-associated neurological complications.
Identifiants
pubmed: 31089783
doi: 10.1007/s00115-019-0712-8
pii: 10.1007/s00115-019-0712-8
doi:
Substances chimiques
Antineoplastic Agents
0
Types de publication
Journal Article
Review
Langues
ger
Sous-ensembles de citation
IM
Pagination
587-593Références
Neurology. 2007 Aug 14;69(7):707
pubmed: 17698797
Nat Rev Clin Oncol. 2009 Aug;6(8):465-77
pubmed: 19581909
Lancet Oncol. 2010 Nov;11(11):1057-65
pubmed: 20864405
Leukemia. 2012 Apr;26(4):595-608
pubmed: 22193964
Blood. 2015 Dec 24;126(26):2798-804
pubmed: 26377597
N Engl J Med. 2016 Apr 28;374(17):1621-34
pubmed: 27119237
Lancet Oncol. 2016 Dec;17(12):e529-e541
pubmed: 27924751
Curr Opin Neurol. 2018 Oct;31(5):575-582
pubmed: 30080718